Riskpilot← Back to searchSign inGet full accessDr. Agata Bohlin Derma Unit AB
ABActiveOrg 5591426704Lilla Badhusgatan 2-4Medical specialists activities · NACE 8622Est. 20171 employees
Revenue 2025
SEK 2,7M
-3% vs 2024
EBITDA margin
31.1%
+391% vs 2024
Equity ratio
60.2%
Financial strength
Net profit 2025
SEK 666K
+1477% vs 2024
| Revenue | SEK 2,7M | -3% |
| EBITDA | SEK 852K | +391% |
| Net profit | SEK 666K | +1477% |
| Total assets | SEK 2,3M | +45% |
| Equity | SEK 1,4M | +90% |
| Employees | 1 | — |
Legal name
Dr. Agata Bohlin Derma Unit AB
Org number
5591426704
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
28 december 2017
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolaget ska bedriva tjänster inom hudsjukvård, hudvård och skönhet. Aktiebolaget ska erbjuda olika typer av estetiska behandlingar, så som injektionsbehandlingar, laserbehandlingar m.m., samt föredragshållning och utbildning inom dessa ämnen. Försäljning av hudvårdsprodukter. Aktiebolagen ska bedriva läkarvårdstjänster inom specialiteten hud- och könssjukdomar.
Address
Lilla Badhusgatan 2-4
Email
agata.bohlin@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 3 825 | 3 528 | 4 106 | 2 816 | 2 743 |
| Staff expenses | — | −858 | — | −866 | −776 |
| EBITDA | 1 048 | 424 | 1 081 | −293 | 852 |
| Depreciation & amort. | −9 | −9 | −9 | −9 | −9 |
| EBIT | 1 039 | 414 | 1 072 | −303 | 843 |
| Net financials | — | 2 | 35 | 29 | 4 |
| Profit before tax | 775 | 311 | 830 | 65 | 847 |
| Tax | −164 | −68 | −176 | −23 | −180 |
| Net profit | 611 | 243 | 654 | 42 | 666 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2 610 | 2 219 | 3 106 | 1 619 | 2 341 |
| Equity | 671 | 640 | 1 013 | 743 | 1 409 |
| Long-term debt | 0 | — | 0 | — | — |
| Short-term debt | 1 331 | 865 | 1 102 | 224 | 280 |
| Total debt | 1 331 | 865 | 1 102 | 224 | 280 |
EBITDA margin
31.1%
This company
15.8%
Market median
+97% vs market
20212025
Equity ratio
60.2%
This company
38.2%
Market median
+58% vs market
20212025
Return on equity
47.3%
This company
18.4%
Market median
+157% vs market
20212025
Net profit margin
24.3%
This company
8.1%
Market median
+200% vs market
20212025
Asset turnover
1.17×
This company
1.12×
Market median
+4% vs market
20212025
Debt / equity
0.66×
This company
0.62×
Market median
+6% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
CK Chief Auditor | Chief Auditor | 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2025 | |
| Board of Directors | 2020 | |
| Former (2) | ||
| Deputy Board Member | 2020 – 2022 | |
| Deputy Board Member | 2022 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Dr. Agata Bohlin Derma Unit AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Chang Kit Lawrence Liu | Chief Auditor | 0 companies |
| Christin Elisabeth Wahlström | Deputy Board Member | 0 companies |
| Mattias Bohlin | Deputy Board Member | 0 companies |
| Agata Bohlin | Board of Directors | 0 companies |
| Dorota Helena Falke | Deputy Board Member | 0 companies |